Contraceptive pills are among the most popular contraception methods worldwide. A combined oral contraceptive pill contains two components, the estrogen and the progestagen compound. Despite its reliable contraception action, these pills may present side-effects including obstruction of leg and pulmonary vessels by clots (venous thrombosis). This side-effect is rare but the most frequently occurring serious adverse effect. Different combination pills show different vessel clotting obstruction tendencies (venous thrombosis risk). Evaluation of these different tendencies may play an important role in choosing the safest pill when starting pill use. COC containing higher estrogen doses (>30 μg) with levonorgestrel (a progestagen) or containing cyproterone acetate or drospirenone as progestagen are associated with higher VT risk than the oral contraceptive pill with 30 μg estrogen and levonorgestrel as progestagen. All combined monophasic oral contraceptive pills have the same effectiveness, that is preventing unwanted pregnancies.
Contraceptive pills and venous thrombosis
3 March 2014
This record should be cited as:
de Bastos M, Stegeman BH., Rosendaal FR., Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Combined oral contraceptives: venous thrombosis. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD010813. DOI: 10.1002/14651858.CD010813.pub2
Assessed as up to date:
30 December 2013
More like this
- Combined intermittent pneumatic leg compression and medication for the prevention of deep vein thrombosis and pulmonary embolism in high-risk patients
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Prevention of blood clots in non-hospitalised cancer patients receiving chemotherapy
- Does the speed of injection make a difference to the amount of pain and bruising in people having heparin injections?
- The use of anticoagulants to prevent deep venous thrombosis and pulmonary embolism following surgery for abdominal aortic aneurysm